A
$ Value
$0
Shares
107,400
Price
$0
Filed
May 30
Insider
Name
Stehman-Breen Catherine
Title
—
CIK
0001702233
Roles
Director
Transaction Details
Transaction Date
2025-05-29
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
107,400
Footnotes
Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 29, 2026, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date.
Filing Info
Stehman-Breen Catherine's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-09 | GBIO | U | — |
| 2026-02-09 | GBIO | D | — |
| 2026-02-09 | GBIO | D | — |
| 2026-02-09 | GBIO | D | — |
| 2026-02-09 | GBIO | D | — |
| 2026-02-09 | GBIO | D | — |
| 2026-02-09 | GBIO | D | — |
| 2025-06-04 | GBIO | A | $0 |
| 2025-05-30 | DYN | A | $0 |
| 2025-05-29 | TNYA | A | $0 |
Other Insiders at TNYA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Ali Faraz
Chief Executive Officer
|
— | $10K | 2026-02-17 |
| COLUMN GROUP III GP, LP | — | $5.9M | 2026-02-25 |
|
Tingley Whittemore
Chief Medical Officer
|
— | $3K | 2026-02-17 |
|
Higa Tomohiro
SVP, Finance
|
— | $2K | 2026-02-17 |